Rare diseases
Investigational molecules
Locations
Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
CzechiaStudy of Niraparib and Dostarlimab for Children with Recurrent or Hard-to-Treat Solid Tumors
CzechiaStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
CzechiaStudy on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma
CzechiaStudy on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis
CzechiaStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
CzechiaStudy of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
CzechiaLong-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks
CzechiaStudy on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma
CzechiaStudy on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
